Literature DB >> 17585107

Acute exacerbations of idiopathic pulmonary fibrosis.

Harold R Collard1, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman, Ganesh Raghu, Jesse Roman, Jay H Ryu, David A Zisman, Gary W Hunninghake, Thomas V Colby, Jim J Egan, David M Hansell, Takeshi Johkoh, Naftali Kaminski, Dong Soon Kim, Yasuhiro Kondoh, David A Lynch, Joachim Müller-Quernheim, Jeffrey L Myers, Andrew G Nicholson, Moisés Selman, Galen B Toews, Athol U Wells, Fernando J Martinez.   

Abstract

The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady, predictable decline in lung function over time. Recent evidence suggests that some patients may experience a more precipitous course, with periods of relative stability followed by acute deteriorations in respiratory status. Many of these acute deteriorations are of unknown etiology and have been termed acute exacerbations of IPF. This perspective is the result of an international effort to summarize the current state of knowledge regarding acute exacerbations of IPF. Acute exacerbations of IPF are defined as acute, clinically significant deteriorations of unidentifiable cause in patients with underlying IPF. Proposed diagnostic criteria include subjective worsening over 30 days or less, new bilateral radiographic opacities, and the absence of infection or another identifiable etiology. The potential pathobiological roles of infection, disordered cell biology, coagulation, and genetics are discussed, and future research directions are proposed.

Entities:  

Mesh:

Year:  2007        PMID: 17585107      PMCID: PMC2094133          DOI: 10.1164/rccm.200703-463PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  78 in total

1.  Anticoagulant therapy and idiopathic pulmonary fibrosis.

Authors:  Brent W Kinder; Harold R Collard; Talmadge E King
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

Review 2.  Structure and function of matrix metalloproteinases and TIMPs.

Authors:  Hideaki Nagase; Robert Visse; Gillian Murphy
Journal:  Cardiovasc Res       Date:  2006-01-05       Impact factor: 10.787

Review 3.  Biologic markers of mortality in acute lung injury.

Authors:  Amit Gaggar; Mitchell A Olman
Journal:  Clin Chim Acta       Date:  2006-06-22       Impact factor: 3.786

4.  Acute exacerbation of interstitial fibrosis after pulmonary resection.

Authors:  Mustafa Yüksel; Mehmet Oguzhan Ozyurtkan; Korkut Bostanci; Rengin Ahiskali; Nihat Kodalli
Journal:  Ann Thorac Surg       Date:  2006-07       Impact factor: 4.330

Review 5.  The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease?

Authors:  William E Lawson; James E Loyd
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 6.  Classification and natural history of the idiopathic interstitial pneumonias.

Authors:  Dong Soon Kim; Harold R Collard; Talmadge E King
Journal:  Proc Am Thorac Soc       Date:  2006-06

7.  [Clinical analysis of the acute exacerbation in patients with idiopathic pulmonary fibrosis].

Authors:  Tatsuya Okamoto; Hidenori Ichiyasu; Kazuya Ichikado; Hiroyuki Muranaka; Keizo Sato; Shinichiro Okamoto; Kazuhiro Iyonaga; Moritaka Suga; Hirotsugu Kohrogi
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2006-05

8.  Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series.

Authors:  Ganesh Raghu; Steve T-Y Yang; Carolyn Spada; Jennifer Hayes; Carlos A Pellegrini
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

9.  The role of CCL12 in the recruitment of fibrocytes and lung fibrosis.

Authors:  Bethany B Moore; Lynne Murray; Anuk Das; Carol A Wilke; Amy B Herrygers; Galen B Toews
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-16       Impact factor: 6.914

10.  Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane?

Authors:  Kristian Nihlberg; Kristoffer Larsen; Anna Hultgårdh-Nilsson; Anders Malmström; Leif Bjermer; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2006-03-29
View more
  316 in total

1.  Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β.

Authors:  Payal N Naik; Jeffrey C Horowitz; Thomas A Moore; Carol A Wilke; Galen B Toews; Bethany B Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

2.  Clinical trials and tribulations--lessons from pulmonary fibrosis.

Authors:  A L Olson; J J Swigris; K K Brown
Journal:  QJM       Date:  2012-05-29

3.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

4.  Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Carolyn S Calfee; Paul J Wolters; Jin Woo Song; Sang-Bum Hong; Sandra Brady; Akitoshi Ishizaka; Kirk D Jones; Talmadge E King; Michael A Matthay; Dong Soon Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-23       Impact factor: 5.464

5.  Eosinophilic pneumonia associated with pirfenidone therapy.

Authors:  Diana C Gomez; Borna Mehrad
Journal:  Eur Respir J       Date:  2016-07-07       Impact factor: 16.671

6.  Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Susan E Yount; Jennifer L Beaumont; Shih-Yin Chen; Karen Kaiser; Katy Wortman; David L Van Brunt; Jeffrey Swigris; David Cella
Journal:  Lung       Date:  2016-02-09       Impact factor: 2.584

Review 7.  The diagnosis and treatment of idiopathic pulmonary fibrosis.

Authors:  Jürgen Behr
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

8.  Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.

Authors:  Sean J Callahan; Meng Xia; Susan Murray; Kevin R Flaherty
Journal:  Respir Med       Date:  2016-08-31       Impact factor: 3.415

9.  Analysis of blood neutrophil elastase, glutathione levels and pathological findings in postoperative acute exacerbation of idiopathic pulmonary fibrosis associated with lung cancer: Two case reports.

Authors:  Keishi Sugino; Yasuhiko Nakamura; Yoko Muramatsu; Yoshinobu Hata; Kazutoshi Shibuya; Sakae Homma
Journal:  Mol Clin Oncol       Date:  2016-08-12

10.  Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.

Authors:  Ronald A Reilkoff; Hong Peng; Lynne A Murray; Xueyan Peng; Thomas Russell; Ruth Montgomery; Carol Feghali-Bostwick; Albert Shaw; Robert J Homer; Mridu Gulati; Aditi Mathur; Jack A Elias; Erica L Herzog
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.